We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$2.15B
AUM Growth
+$118M
Cap. Flow
-$23.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
21.24%
Holding
336
New
80
Increased
75
Reduced
61
Closed
59

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$30.6M
2
FE icon
FirstEnergy
FE
+$26.5M
3
PM icon
Philip Morris
PM
+$20.6M
4
AET
Aetna Inc
AET
+$18.7M
5
TMO icon
Thermo Fisher Scientific
TMO
+$18.2M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$31M
2
WMT icon
Walmart Inc
WMT
+$28.2M
3
ABBV icon
AbbVie
ABBV
+$24.6M
4
MO icon
Altria Group
MO
+$24M
5
PG icon
Procter & Gamble
PG
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 19.02%
2 Technology 13.86%
3 Healthcare 12.39%
4 Industrials 9.37%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$69B
$102M 4.74%
6,318,686
-139,679
-2% -$1.97M
HPQ icon
2
HP
HPQ
$24.9B
$54.9M 2.56%
2,947,207
+1,112,902
+61% +$16.8M
UBS icon
3
UBS Group
UBS
$173B
$48.5M 2.26%
2,881,678
+744,401
+35% +$11.2M
MSFT icon
4
Microsoft
MSFT
$3.45T
$43.5M 2.03%
688,098
+495
+0.1% +$29.8K
INTC icon
5
Intel
INTC
$455B
$41.3M 1.92%
1,119,869
+88,028
+9% +$3.15M
AAPL icon
6
Apple
AAPL
$4.54T
$37.8M 1.76%
1,289,104
-239,872
-16% -$6.8M
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$36M 1.68%
310,425
-166,701
-35% -$19.3M
MRK icon
8
Merck
MRK
$322B
$34M 1.58%
599,552
+522,073
+674% +$30.6M
TWX
9
DELISTED
Time Warner Inc
TWX
$31.6M 1.47%
324,559
+14,426
+5% +$1.28M
PEP icon
10
PepsiCo
PEP
$190B
$26.7M 1.25%
253,369
+75,834
+43% +$7.94M
FE icon
11
FirstEnergy
FE
$28B
$25.9M 1.21%
+828,683
New +$26.5M
CSX icon
12
CSX Corp
CSX
$93.4B
$25.1M 1.17%
2,068,935
+1,524,654
+280% +$17.1M
T icon
13
AT&T
T
$159B
$24.3M 1.13%
748,735
+478,550
+177% +$14.1M
PM icon
14
Philip Morris
PM
$297B
$23.6M 1.1%
256,066
+222,423
+661% +$20.6M
PFE icon
15
Pfizer
PFE
$143B
$23.5M 1.1%
759,735
+563,148
+286% +$17.2M
SPG icon
16
Simon Property Group
SPG
$74.4B
$23.3M 1.09%
131,945
+90,537
+219% +$16.8M
EXC icon
17
Exelon
EXC
$47.2B
$23.3M 1.09%
910,464
+209,770
+30% +$4.97M
CSCO icon
18
Cisco
CSCO
$457B
$22.4M 1.05%
732,780
-77,593
-10% -$2.37M
UAL icon
19
United Airlines
UAL
$39.4B
$22M 1.02%
298,633
+123,935
+71% +$7.9M
BBY icon
20
Best Buy
BBY
$18.2B
$21.7M 1.01%
500,191
+74,740
+18% +$3.18M
TD icon
21
Toronto Dominion Bank
TD
$198B
$20.2M 0.94%
406,200
+33,000
+9% +$1.54M
AET
22
DELISTED
Aetna Inc
AET
$19.6M 0.91%
+156,382
New +$18.7M
PEG icon
23
Public Service Enterprise Group
PEG
$38.2B
$19.1M 0.89%
430,748
+32,777
+8% +$1.37M
RY icon
24
Royal Bank of Canada
RY
$291B
$18.9M 0.88%
278,000
-6,000
-2% -$389K
KHC icon
25
Kraft Heinz
KHC
$30.7B
$18.7M 0.87%
+211,439
New +$18.1M

Similar funds

Meag Munich Ergo's Q4 2016 Portfolio in Review

As of Q4 2016, Meag Munich Ergo held 336 positions worth $2.15B, up 5.8% from $2.03B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Meag Munich Ergo's Q4 2016 filing shows 80 new, 75 increased, 61 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 828,683 shares worth $25.9M. The largest sale was Colgate-Palmolive, an estimated $31M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Meag Munich Ergo's largest Q4 2016 buy was FirstEnergy: 828,683 shares worth $25.9M.
  • Meag Munich Ergo added most to Merck in Q4 2016, an estimated $30.6M increase.
  • Meag Munich Ergo's biggest Q4 2016 reduction was Colgate-Palmolive, cutting an estimated $31M.
  • Meag Munich Ergo fully exited Altria Group in Q4 2016, selling an estimated $24M.
  • Meag Munich Ergo's ten largest holdings make up 21% of its $2.15B portfolio in Q4 2016.
  • Meag Munich Ergo opened 80 new positions and closed 59 in Q4 2016.
  • Meag Munich Ergo's portfolio value rose 5.8% quarter-over-quarter to $2.15B.

Based on Meag Munich Ergo's 13F filing for Q4 2016, filed 25 Jan 2017.